Pediatrics Doctors in Jackson, MS Accepting Medicare

214 Pediatrics doctors found. Showing 181 - 200

Ms. Claudine Brown, MD Pediatrics - Pediatric Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-815-2005

Dr. Amy Balducci Shepherd, M.D. Pediatrics - Pediatric Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-2000

Dr. Dana Lanell Grant, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1824 Hospital Dr, Jackson, MS 39204 Phone: 601-346-4586    Fax: 601-346-4587

Mobolaji Eniola Famuyide, MD, MPH Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 2500 N State St, Division Of Newborn Medicine, Univ Of Ms Medical Center, Jackson, MS 39216 Phone: 601-984-5260    Fax: 601-815-3666

William Needham, NNP-BC Pediatrics - Neonatal-Perinatal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-815-7100

Jeffrey Crout, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5200

Dr. Erin Audrey Marie Jackson, M.D Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2500 North State Street, Jackson, MS 39216 Phone: 601-984-5220

Dr. Denisse Leticia Staufert Gutierrez, MD Pediatrics - Developmental – Behavioral Pediatrics Medicare: Medicare Enrolled Practice Location: 4400 Old Canton Rd Fl 3, Jackson, MS 39211 Phone: 888-815-2005

Philip G. Rhodes, M.D. Pediatrics - Neonatal-Perinatal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-815-7100

Charles H Gaymes, M.D. Pediatrics - Pediatric Cardiology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5250    Fax: 601-984-5283

Dr. John Joel Donaldson, M.D. FAAP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5200

Paul Harmon Parker Jr., M.D. Pediatrics - Pediatric Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5232

Dana Dillistone, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000

Mariano L Orca, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1860 Chadwick Dr Ste 351, Jackson, MS 39204 Phone: 601-376-1288    Fax: 601-376-1293

Jennifer Ling Hong, MD Pediatrics - Pediatric Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5214

Jagdish Desai, M.D. Pediatrics - Neonatal-Perinatal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-815-7158

Susie B Phillips, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-2940    Fax: 601-984-2926

Mr. Abhay J. Bhatt, M.D. Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-815-7100

Amanda S Penny, M.D Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1867 Crane Ridge Dr, Suite 101b, Jackson, MS 39216 Phone: 601-362-8776

Dr. Melora Wiley, M.D. Pediatrics - Developmental – Behavioral Pediatrics Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5239

News Archive

Genervon reports new findings that drug candidate GM6 attenuates Alzheimer's disease in mice model

Following the closure of several research programs for Alzheimer's disease, in early 2018 the FDA issued a release entitled "Draft Guidance for Industry: Early Alzheimer's Disease: Developing Drugs for Treatment." Encouraged by the proposed changes in the new guidance, Genervon's research team reported new findings that its drug candidate GM6 attenuates Alzheimer's disease in an early AD transgenic APP mice model.

AstraZeneca, Inserm to investigate new therapeutic approaches to type 2 diabetes, CKD

AstraZeneca today announced a three-year research collaboration with the French National Institute of Health and Medical Research (Inserm) to investigate new therapeutic approaches totype 2 diabetes and Chronic Kidney Disease.

New biological process stimulates the growth of blood vessels

Researchers at the University of North Carolina at Chapel Hill School of Medicine and the College of Arts & Sciences have identified a new biological process that spurs the growth of new blood vessels.

Researchers create novel way to enhance MRI

Researchers at New York University and NYU Langone Medical Center have created a novel way to enhance MRI by reducing interference from large macromolecules that can often obscure images generated by current chemical exchange saturation transfer methods.

Gilead stops ARTEMIS-IPF ambrisentan Phase III clinical trial in idiopathic pulmonary fibrosis

Gilead Sciences, Inc. today announced it is stopping ARTEMIS-IPF, the company's ongoing Phase III clinical trial of ambrisentan in patients with idiopathic pulmonary fibrosis (IPF), due to lack of efficacy. This decision follows an interim analysis of unblinded efficacy and safety data by the study's Data Monitoring Committee (DMC) and review of those data by Gilead, which did not show evidence of a treatment benefit in the group of patients randomized to receive ambrisentan.

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10(current)
• 11